Science and Enterprise

Tag: equity

  • $525M Venture Fund to Back Tech, Science Companies

    The venture capital company Kleiner Perkins Caufield & Byers in Menlo Park, California has closed a $525 million venture capital fund for equity investments in early-stage green technology and life sciences, as well as digital enterprise companies. The fund, Kleiner Perkins Caufield & Byers XV LLC (KPCB 15) will be led by 10 of the…

  • Semiconductor Venture Investment Jumps in April

    Venture capital investments in semiconductor companies worldwide rose significantly in April 2012, compared both to March and April 2011. The Global Semiconductor Alliance in London compiles and publishes these statistics each month. The organization reports that semiconductor companies received $194.2 million in venture capital in April 2012, a 10-fold increase over March 2012, and more…

  • Biomaterials Developer Lands $10 Million Series C Funds

    Regentis Biomaterials Ltd., based in Or Akiva, Israel and Princeton, New Jersey, has secured $10 million in series C funds, the third round of financing after initial start-up. New investors Royal DSM and Crossroad Fund, and existing investors Medica Venture Partners, SCPVitalife and the Technion Investment Opportunities Fund contributed to the round. The company’s lead…

  • Report: Investment Increasing In Water Technologies

    A new report by the London Environmental Investment Forum says venture capital (VC) investors are showing more interest in technologies related to water used in extractive industries, such as oil, gas, and mining. The report, “Water Innovation in Extractive Industries,” can be downloaded from the organization’s Web site. London Environmental Investment Forum is owned and…

  • Group Plans Increased VC Funds for Women, Diverse Start-Ups

    A new program aims to increase venture capital funding for new start-up companies owned by women and diverse minority entrepreneurs. The Venture Capital Access Program (VCAP) is a partnership of the National Association of Investment Companies, Harvard Business School Alumni Angels of Greater New York, and the Marathon Foundation. Applications close on Friday 18 May.…

  • UC-Davis Incubator Spins Off Audio Technology Company

    The business incubator at the University of California in Davis engineering school says an audio technology company is the incubator’s first spin-off to gain funding and begin doing business on its own. Dysonics, founded by emeritus engineering professor Ralph Algazi and colleagues at UC-Davis, is commercializing research conducted in Algazi’s labs. Dysonics plans to develop…

  • Biotech Lands $20M Series A Funds for Protein Therapies

    Eleven Biotherapeutics in Cambridge, Massachusetts has secured an additional $20 million in series A funds, the first round of investment financing after initial start-up. A new investor, JAFCO Company Ltd in Tokyo, joins existing investors Third Rock Ventures and Flagship Ventures in the deal. Eleven Biotherapeutics is expected to use the proceeds from the financing…

  • Investors to Back Start-Ups That Cut Health Care Costs

    The Paliwoda Group in New York has started a new investment fund that plans to support early-stage companies with solutions aimed at cutting the costs of health care. The company’s Health Tech Fund is now accepting proposals on its Web site. The Health Tech Fund plans to invest in early-stage companies with projects having the…

  • Cancer Institute Spin-Off Lands New €3 Million Financing

    iTeos Therapeutics SA, a drug discovery company in Gosselies, Belgium, has secured €3 million ($3.94 million) in  series A financing, the first investment round after starting up. The company received its initial seed funding, totaling €6 million, in December 2011. iTeos Therapeutics is a joint spin-off company of the Ludwig Institute for Cancer Research in…

  • Biopharm Lands $25M Venture Funding for Phase 3 Trial

    Argos Therapeutics Inc., a biopharmaceutical company in Durham, North Carolina, says it secured $25 million in series D venture financing, the fourth funding installment after initial start-up. The funds are expected to support a planned clinical trial of Argos Therapeutics’ immunotherapy for metastatic renal cell carcinoma, a form of kidney cancer. The financing was led…